Clinical Trial Update: Necrotizing Enterocolitis (Nec) and B. Lactis in Premature Babies [NA]

View source ↗

Summary

The Nestlé SPN-sponsored clinical trial evaluating Bifidobacterium lactis for necrotizing enterocolitis in premature infants was terminated; no results are prov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis

Drugs mentioned

• Bifidobacterium lactis (Bifidobacterium lactis)

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Necrotizing Enterocolitis | NA | Status: TERMINATED